Patents by Inventor Thierry Baussant

Thierry Baussant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10732318
    Abstract: A biosensor device (10) for in situ monitoring of deep-water sea-floor biological patterns (30), which biosensor platform (10) comprises a plurality of cameras (12) and a lightening system (14), wherein a plurality of coral nubbins (16) with a plurality of polyps (18) are prepared and fixed to a platform (11) of the biosensor platform (10) with a distance to each other such that there is no overlap on a picture frame (22) thereof, and wherein the cameras (12) and the lightening system (14) are arranged so as to take coral-silhouette-pictures (CSP:s) of the plurality of nubbins (16) in the picture frame (22). In this way, there is provided a biosensor device based on coral, or other deep-sea species, behavioural for surveillance and monitoring of a deep-water sea-floor.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: August 4, 2020
    Assignee: NORCE Norwegian Research Centre A
    Inventor: Thierry Baussant
  • Publication number: 20170276829
    Abstract: A biosensor device (10) for in situ monitoring of deep-water sea-floor biological patterns (30), which biosensor platform (10) comprises a plurality of cameras (12) and a lightening system (14), wherein a plurality of coral nubbins (16) with a plurality of polyps (18) are prepared and fixed to a platform (11) of the biosensor platform (10) with a distance to each other such that there is no overlap on a picture frame (22) thereof, and wherein the cameras (12) and the lightening system (14) are arranged so as to take coral-silhouette-pictures (CSP:s) of the plurality of nubbins (16) in the picture frame (22). In this way, there is provided a biosensor device based on coral, or other deep-sea species, behavioural for surveillance and monitoring of a deep-water sea-floor.
    Type: Application
    Filed: August 21, 2015
    Publication date: September 28, 2017
    Inventor: Thierry Baussant
  • Publication number: 20150080302
    Abstract: The present invention relates to new therapeutic and diagnostic uses of soluable neuregulin-1 isoforms and polypeptides, particularly neurological disorders.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Thierry Baussant, Daniel Bach, André Schrattenholz
  • Publication number: 20130072437
    Abstract: The present invention relates to new therapeutic and diagnostic uses of soluble neuregulin-1 isoforms and polypeptides, particularly neurological disorders.
    Type: Application
    Filed: May 27, 2011
    Publication date: March 21, 2013
    Applicant: MIND-NRG SA
    Inventors: Thierry Baussant, Daniel Bach, André Schrattenholz
  • Patent number: 7408044
    Abstract: The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: August 5, 2008
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thierry Baussant, Jean-François Haeuw, Thien Ngoc Nguyen
  • Patent number: 7220545
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130–230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: May 22, 2007
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc N′Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 7125696
    Abstract: A invention concerns a novel method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent, and polypeptides obtainable by said method. The invention also concerns the use of said polypeptides, in particular for preparing medicines or vaccines, for fighting against bacterial and viral infections or cancers.
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: October 24, 2006
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Baussant, Pascale Jeannin, Yves Delneste, François Lawny, Jean-Yves Bonnefoy
  • Publication number: 20060034870
    Abstract: The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
    Type: Application
    Filed: April 1, 2004
    Publication date: February 16, 2006
    Inventors: Hans Binz, Thierry Baussant, Jean-Francois Haeuw, Thien Nguyen
  • Publication number: 20050250933
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Application
    Filed: September 5, 2003
    Publication date: November 10, 2005
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Hans Binz, Thien N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6780420
    Abstract: The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: August 24, 2004
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thierry Baussant, Jean-François Haeuw, Thien Nguyen Ngoc
  • Patent number: 6616930
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: September 9, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc N'Guyen, Thierry Baussant, Michel Trudel
  • Publication number: 20030064078
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Application
    Filed: March 5, 2002
    Publication date: April 3, 2003
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Hans Binz, Thien Ngoc N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6537556
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: March 25, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien N'Guyen Ngoc, Thierry Baussant, Michel Trudel
  • Publication number: 20030044915
    Abstract: The invention concerns a novel method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent, and polypeptides obtainable by said method. The invention also concerns the use of said polypeptides, in particular for preparing medicines or vaccines, for fighting against bacterial and viral infections or cancers.
    Type: Application
    Filed: July 3, 2002
    Publication date: March 6, 2003
    Inventors: Thierry Baussant, Pascale Jeannin, Yves Delneste, Francois Lawny, Jean-Yves Bonnefoy
  • Patent number: 6410030
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: June 25, 2002
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Ngoc Thien N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6197929
    Abstract: The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
    Type: Grant
    Filed: August 11, 1997
    Date of Patent: March 6, 2001
    Inventors: Hans Binz, Thierry Baussant, Jean-François Haeuw, Thien Nguyen Ngoc
  • Patent number: 6113911
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: September 5, 2000
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien N'Guyen Ngoc, Thierry Baussant, Michel Trudel